ArticleScientific reports2023
A global analysis of the effectiveness of policy responses to COVID-19.
Article in Scientific reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
25 citing papers in PubMed, 56 citations in OpenAlex.
- The Long Arm of Childhood Policy: Historical Schooling Laws and COVID-19 Pandemic-era Mortality.Epidemiology (Cambridge, Mass.) · 2026Article
- Enhancing SARS-CoV-2 response capacity in Africa and other centers for research in emerging infectious diseases centres through a collaborative training programme.Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases · 2026Article
- Evidence-based opportunities to address pandemic drivers via the Pandemic Agreement: lessons from the Framework Convention on Tobacco Control.BMJ global health · 2025Article
- The emotional cost of containment: a cross-sectional analysis of treatment effects among informal carers in South Asia during the COVID-19 pandemic.Global health action · 2025Article
- Clustering-based methodology for comparing multi-characteristic epidemiological dynamics with application to COVID-19 epidemiology in Europe.Royal Society open science · 2025Article
- Governance in Crisis: A Mixed-Methods Analysis of Global Health Governance During COVID-19.International journal of environmental research and public health · 2025Review
- Organizational identification moderates the effects of perceived COVID-19 safety climate on COVID-19 safety behavior in employees' personal life: A social identity approach.Applied psychology. Health and well-being · 2025Article
- Article
- Preparing public health researchers to interact with state-level legislators: evaluation of the Texas Research-to-Policy Collaboration project training.Journal of public health policy · 2025Article
- Does Government Trust Matter? The Effectiveness of Policy Responses in the Health-Disaster Era.Healthcare (Basel, Switzerland) · 2025Article
- Assessing COVID-19 Mortality in Serbia's Capital: Model-Based Analysis of Excess Deaths.JMIR public health and surveillance · 2025Article
- Pandemic Social Distancing and Declines in Nasopharyngeal Carriage of Pneumococcus and Related Antimicrobial-Resistant Genes: Evidence From Household-Based Cohort Studies in Lima, Peru.Open forum infectious diseases · 2025Article
- Trends and cross-country inequalities in dengue, 1990-2021.PloS one · 2025Article
- The global response to the pandemic: An empirical cluster analysis of policies targeting COVID-19.PloS one · 2025Article
- Exploring the nexus of urban form, transport, environment and health in large-scale urban studies: A state-of-the-art scoping review.Environmental research · 2024Article
- PHIRI: lessons for an extensive reuse of sensitive data in federated health research.European journal of public health · 2024Article
- Examining the cultural influence on online stances towards COVID-19 preventive measures and their impact on incidence and mortality: A global stance detection analysis of tweets.SSM - population health · 2024Article
- Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the Phase 3 KEEPsAKE 1 Randomized Clinical Trial.Rheumatology and therapy · 2024Article
- Efficacy and Safety of Risankizumab for Active Psoriatic Arthritis: 100-Week Results from the KEEPsAKE 2 Randomized Clinical Trial.Rheumatology and therapy · 2024Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Governments implemented many non-pharmaceutical interventions (NPIs) to suppress the spread of COVID-19 with varying results. In this paper, country-level daily time series from Our World in Data facilitates a global analysis of the propagation of the virus, policy responses and human mobility patterns. High death counts and mortality ratios influence policy compliance levels. Evidence of long-term fatigue was found with compliance dropping from over 85% in the first half of 2020 to less than 40% at the start of 2021, driven by factors such as economic necessity and optimism coinciding with vaccine effectiveness. NPIs ranged from facial coverings to restrictions on mobility, and these are compared using an empirical assessment of their impact on the growth rate of case numbers. Masks are the most cost-effective NPI currently available, delivering four times more impact than school closures, and approximately double that of other mobility restrictions. Gathering restrictions were the second most effective. International travel controls and public information campaigns had negligible effects. Literacy rates and income support played key roles in maintaining compliance. A 10% increase in literacy rate was associated with a 3.2% increase in compliance, while income support of greater than half of previous earnings increased compliance by 4.8%.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.